Halogenated Flavonoid Derivatives Display Antiangiogenic Activity
Antiangiogenic agents attenuate tumours’ growth and metastases and are therefore beneficial as an adjuvant or standalone cancer regimen. Drugs with dual antiproliferative and antiangiogenic activities can achieve anticancer efficacy and overcome acquired resistance. In this study, synthetic flavones...
Main Authors: | Mai Khater, Kimberly A. Watson, Samuel Y. Boateng, Francesca Greco, Helen M. I. Osborn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/15/4757 |
Similar Items
-
Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis
by: Mai Khater, et al.
Published: (2020-10-01) -
Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectives
by: Azhar U. Khan, et al.
Published: (2021-12-01) -
Nutraceuticals: Dietary Flavonoids
by: Irene M. Villasenor
Published: (2011-06-01) -
Anti-Neurodegenerating Activity: Structure–Activity Relationship Analysis of Flavonoids
by: Gagan Preet, et al.
Published: (2023-10-01) -
Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
by: Alicia González, et al.
Published: (2021-06-01)